Would you inject yourself with the Sinovac?
Sinovac is a Chinese company that developed a corona virus vaccine called “CoronaVac”. The vaccine is approved for use in China and authorized for emergency use in more than a dozen other countries. CoronaVac works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
To create CoronaVac, the Sinovac researchers started by obtaining samples of the coronavirus from patients in China, Britain, Italy, Spain and Switzerland. One sample from China eventually served as the basis for the vaccine. From the sample, the researchers grew large stocks of the coronavirus in monkey kidney cells. Then they doused the viruses with a chemical called beta-propiolactone. The compound disabled the coronaviruses by bonding to their genes. The inactivated coronaviruses could no longer replicate. But their proteins, including spike, remained intact.
The researchers then drew off the inactivated viruses and mixed them with a tiny amount of an aluminum-based compound called an adjuvant. Adjuvants stimulate the immune system to boost its response to a vaccine. Aluminum is a neurotoxin. Aluminum is present in the human brain and it accumulates with age. Moreover, fluoride makes our body absorb extra aluminum, and fluoride is present in our toothpastes and drinking water.
The CoronaVac is a viral vector vaccine that uses a modified Ad5 (Adenovirus 5) virus to deliver the blueprint for the SARS-CoV-2 protein spike. Unlike the Pfizer and Moderna mRNA vaccines, CoronaVac only needs to be refrigerated at 2–8 °C (36–46 °F), which makes it easy to distribute. In addition, it only requires a single dose, which makes it easier to fully vaccinate large populations.
The CoronaVac works similarly to other viral vector vaccines, like the AstraZeneca AZD1222 and Gamaleya Sputnik V vaccines. It uses a modified Ad5 virus containing the DNA instructions for the protein spikes of the SARS-CoV-2. Once injected, the Ad5 virus introduces the SARS-CoV-2 protein spike DNA to the cell nucleus, where it is decoded to create the mRNA instructions. Then, just like the mRNA vaccines, the cell’s ribosomes use those mRNA instructions to manufacture the SARS-CoV-2 protein spikes, which are then presented on the cell surface. These “foreign” protein spikes triggers the body’s immune system, which then makes antigens to target those spikes.
Sinovac is used in China, Chile, Brazil, Turkey, and the Philippines. The Ad5 vector was developed through Gain-of-Function research. U.S. patent #10695417 is about human Ad5 vector that contains E1 and E2B gene deletions. The Ad5 encodes the cells with Ebola Glycoprotein. Glycoprotein -41 and glycoprotein -120 are HIV viral coat Proteins and Glycoprotein plays a key role in reproduction.
E1 gene deletion causes embryonic lethality which means permanent sterility for men and women. It causes Lactic Acidosis in children which is the lack of oxygen in the blood. E1 gene deletion causes rapid cancer growth, Thrombosis, and the coagulation of the blood which leads to clotting. Blood clotting is the main reason people are dying from the COVID vaccines.
E1 gene deletion causes Mitochondrial DNA-Associated Syndrome which is a process of glucose metabolism deficiency that exists in various diseases such as Alzheimer’s, epilepsy, diabetes-associated cognitive decline, and severe neurological disorders such as Leigh’s Syndrome. There’s a progressive loss of mental cognition and typically results in death within two or three years, usually due to respiratory failure. Without your E1 gene, your cells will literally self-suicide. Knocking out the E2B gene caused sterilization in male mice.
References:
EPIGENETICS: Vaccines Are Deleting Human Genes & Transfecting Cells With Ebola/Marburg